Smart ventilators under the microscope: can automation save lives?

NCT ID NCT06655805

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is observing 1,000 adults in intensive care who need breathing support from machines like ventilators or high-flow oxygen. Researchers want to see how well automated software settings keep patients safe and within recommended breathing ranges. No new treatment is being tested—just real-world data collection to improve future care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help improve automated ventilation software to make breathing support safer and more effective for ICU patients.
What could go wrong
This is an observational registry, not a treatment trial. It collects data but does not test a new therapy, so direct patient benefits are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY INSUFFICIENCY REQUIRING MECHANICAL VENTILATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • HOCH Health Ostschweiz, Clinics for Intensive Care Medicine, Medical ICU

    RECRUITING

    Sankt Gallen, St.Gallen, 9007, Switzerland

  • HOCH Health Ostschweiz, Clinics for Intensive Care Medicine, Surgical ICU

    RECRUITING

    Sankt Gallen, Canton of St. Gallen, 9007, Switzerland

  • Kantonsspital Chur

    RECRUITING

    Chur, Kanton Graubünden, 7000, Switzerland

  • Kantonsspital Winterthur, Zentrum für Intensivmedizin

    RECRUITING

    Winterthur, 8400, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.